Coronavirus outbreak hobbles global anti-doping efforts by preventing enforcers from demanding samples

For athletes inclined to cheat with performance-enhancing drugs, the COVID-19 pandemic has presented an extraordinary opportunity: Enforcers for the time being are not going to knock on their doors demanding a urine or blood sample. Nearly every day in normal times, an anti-doping official may be crossing borders, seeking a world-class athlete to submit a sample, while other officials are gathering intelligence, meeting with whistleblowers or working in labs to try to find testing techniques that will put them one step ahead of the cheaters. These are not normal times. Much of that work has ground to a halt in countries that have locked down, urging citizens to stay at home and avoid close contact with other people. This has prevented the anti-doping authorities from pursuing one of the most effective deterrents — testing athletes when they are not competing and cannot predict the timing of a drug test. “It’s why we run year-round, out-of-competition testing programmes,” said Travis Tygart, chief executive of the US Anti-Doping Agency. “COVID-19 has put a serious strain on anti-doping. We’d be foolish to think some weren’t out there doing their best to exploit it so they have a better opportunity when this eventually passes.” Unscrupulous athletes generally take performance-enhancing drugs while training, to test their effectiveness and to get a leg up months before a competition. [caption id=“attachment_4178979” align=“alignleft” width=“380”] Representational image. Reuters[/caption] On Friday, Tygart said that a hiatus for anti-doping regulators could be expected to last several weeks and that the pause could wreak havoc on efforts to control illicit performance enhancement. Athletes tempted to experiment with performance-enhancing drugs now could have a window of opportunity to do so. Reports from Australia on Monday that two officials from that country’s anti-doping agency had tested positive for the novel coronavirus, which causes COVID-19, highlighted the potential complications of resuming testing that is a regular part of an elite athlete’s life. The virus is said to be spreading in Russia, whose Olympic team has been banned from the next Summer Olympics because of a years-long, State-sponsored doping programme. But Russia may still have athletes at the Games competing for a neutral team, provided they can pass a regimen of doping tests. While there are reports that the virus is under control in parts of China and other parts of Asia, Japan has seen a rash of new cases. “At the end of the day, it’s safety first, the health of people first, and that means the health of anti-doping personnel and the health of the athletes,” said Olivier Niggli, director-general of the World Anti-Doping Agency. Traditionally, people who use performance-enhancing drugs do so for a period of a few weeks to a few months. The drugs allow athletes to train harder and recover more quickly, so they become stronger and fitter. Athletes try to time their doping cycles ahead of major competitions, where they are most likely to be tested, but not so far ahead that they can’t sustain the gains they have made with the drugs. Most major athletic competitions have been suspended at least for the next month or two. The International Olympic Committee on Monday announced that the postponed Tokyo Games would take place in July and August of 2021. Niggli said any athlete serving a suspension that extended through this summer’s postponed Olympics but that was due to end before the new dates would be allowed to compete next summer in Tokyo. Any effective testing programme requires at least a six-month lead before a major competition, Niggli said, and that amount of time would not have been available had the Games opened this July as scheduled. National anti-doping agencies and international sports federations typically administer about 300,000 tests annually. They are likely to conduct far fewer this year. Sebastian Coe, president of World Athletics, the governing body for track and field, on Friday described the number of tests as an “old-fashioned” metric to gauge the effectiveness of anti-doping measures, but he acknowledged that the coronavirus was causing problems for anti-doping efforts. “It does clearly pose some challenges,” Coe said. But, he added, “all these organisations are at the top of their game in terms of intelligence gathering.” Indeed, the biggest doping cases — such as Russia’s State-sponsored programme, Lance Armstrong and the US Postal Service cycling team, the Biogenesis scandal of 2013 — usually rely on eyewitness testimony from whistleblowers. Still, Tygart and Niggli said that as soon as travel bans and social distancing guidelines were lifted, anti-doping organisations were likely to pursue an aggressive regimen of testing to try to make up for lost time — perhaps prioritising athletes who have qualified for the Olympics or have qualification competitions approaching. The chemical makeup of the samples gathered will be compared with those the athletes have given in the past, documented in what is known as the biological passport. In the best-case scenario, any athlete who exhibits a change that is deemed unnatural will be scrutinized further and, depending on what else the test reveals, face penalties. No testing regimen is foolproof, however. Cheaters are often one step ahead of testers, and that’s when normal out-of-competition testing is underway. “We’ll do everything we can to maintain a level playing field and protect clean sport,” Witold Bańka, president of WADA, said on Twitter on Saturday, “even in these difficult times.” Matthew Futterman c.2020 The New York Times Company